Bispecific Antibody Therapy
Among lymphoma patients treated with bispecific antibodies, the aetiology of many severe infections has not been reported. CLARITY includes infection outcomes after bispecific antibody therapy in adults with lymphoproliferative neoplasms.
1 sources - 3 claims
Among lymphoma patients treated with bispecific antibodies, the aetiology of many severe infections has not been reported. CLARITY includes infection outcomes after bispecific antibody therapy in adults with lymphoproliferative neoplasms.